Thomas Maldonado

ORCID: 0000-0003-4280-7518
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Venous Thromboembolism Diagnosis and Management
  • Cerebrovascular and Carotid Artery Diseases
  • Peripheral Artery Disease Management
  • Acute Ischemic Stroke Management
  • Ultrasound in Clinical Applications
  • Intracranial Aneurysms: Treatment and Complications
  • Central Venous Catheters and Hemodialysis
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Cardiac, Anesthesia and Surgical Outcomes
  • Diagnosis and Treatment of Venous Diseases
  • Cardiovascular Health and Disease Prevention
  • Sepsis Diagnosis and Treatment
  • COVID-19 Clinical Research Studies
  • Congenital Anomalies and Fetal Surgery
  • Adipokines, Inflammation, and Metabolic Diseases
  • Hemodynamic Monitoring and Therapy
  • Cardiovascular Disease and Adiposity
  • Bone health and osteoporosis research
  • Pelvic floor disorders treatments
  • COVID-19 and healthcare impacts
  • Cardiac Imaging and Diagnostics
  • Craniofacial Disorders and Treatments
  • Cleft Lip and Palate Research
  • Radiation Dose and Imaging
  • Cerebral Venous Sinus Thrombosis

New York University
2000-2024

NYU Langone Health
2020-2024

VA NY Harbor Healthcare System
2024

Columbia University Irving Medical Center
2010-2021

Saint Vincent Hospital
2000

Saint Vincent's Catholic Medical Center
2000

University Medical Center
2000

Abstract Patients with coronavirus disease 2019 (COVID-19) present increased risk for ischemic cardiovascular complications up to 1 year after infection. Although the systemic inflammatory response severe acute respiratory syndrome 2 (SARS-CoV-2) infection likely contributes this risk, whether SARS-CoV-2 directly infects coronary vasculature and attendant atherosclerotic plaques remains unknown. Here we report that viral RNA is detectable replicates in lesions taken at autopsy from COVID-19...

10.1038/s44161-023-00336-5 article EN cc-by Nature Cardiovascular Research 2023-09-28

The left ventricular outflow tract (LVOT) velocity time integral (VTI) is an easily measured echocardiographic stroke volume index analog. Low values predict adverse outcomes in failure. We postulate the VTI may be a signal of right dysfunction acute pulmonary embolism, and therefore predictor poor outcomes. retrospectively reviewed echocardiograms on all Pulmonary Embolism Response Team activations at our institution embolism diagnosis. LVOT was defined as ⩽ 15 cm. examined two composite...

10.1177/1358863x19880268 article EN Vascular Medicine 2019-11-10

ObjectiveEndovenous ablation is the standard of care for patients with symptomatic superficial venous insufficiency. For a history deep vein thrombosis (DVT), concern exists an increased risk postprocedural complications, particularly thromboembolism. The objective this study was to evaluate safety and efficacy endovenous thermal in DVT.MethodsThe national Vascular Quality Initiative Varicose Vein Registry queried procedures performed from January 2014 July 2021. Limbs treated radiofrequency...

10.1016/j.jvsv.2024.101898 article EN cc-by-nc-nd Journal of Vascular Surgery Venous and Lymphatic Disorders 2024-04-25

Coronavirus disease 2019 (COVID-19) is associated with increased rates of deep vein thrombosis (DVT) and pulmonary embolism (PE). Pulmonary Embolism Response Teams (PERT) have previously been improved outcomes. We aimed to investigate whether PERT utilization, recommendations, outcomes for patients diagnosed acute PE changed during the COVID-19 pandemic. This a retrospective cohort study all adult who received care at an academic hospital system in New York City between March 1st April 30th,...

10.1007/s11239-020-02264-8 article EN other-oa Journal of Thrombosis and Thrombolysis 2020-09-10

Autologous great saphenous vein (GSV) is considered the conduit of choice for lower extremity bypass (LEB). However, optimal configuration remains source debate. We compared outcomes patients undergoing LEB using in-situ and reversed techniques.The Vascular Quality Initiative database was queried with a single-segment GSV in (ISGSV) (RGSV) configurations symptomatic occlusive disease from 2003 to 2021. Patient demographics, procedural detail, in-hospital follow-up were collected. The primary...

10.1177/17085381221088082 article EN Vascular 2022-04-22

Venous thromboembolism, including deep venous thrombosis and pulmonary embolism, is a major source of morbidity, mortality, healthcare utilization. Given the prevalence thromboembolism its associated our study sought to identify factors with loss follow-up in patients.This single-center retrospective all consecutive admitted (inpatient) emergency department patients diagnosed acute via duplex examination and/or chest computed tomography from January 2018 March 2019. Patients chronic those...

10.1177/17085381211020969 article EN Vascular 2021-06-03

Clot-in-transit (CIT) is associated with high mortality, but optimal management strategies remain uncertain. The aim of this study was to compare the outcomes different treatment in patients CIT. This a retrospective documented CIT right heart on echocardiography across two institutions between January 2020 and October 2023. primary outcome composite in-hospital resuscitated cardiac arrest hemodynamic decompensation. Among 35 included study, 10 (28.6%) received anticoagulation (AC) alone, 2...

10.1016/j.jscai.2024.101463 article EN cc-by-nc-nd Journal of the Society for Cardiovascular Angiography & Interventions 2024-05-01

Objective Current guidelines recommend dual antiplatelet therapy (DAPT) in patients undergoing carotid artery stenting. The most common DAPT regimen is aspirin and clopidogrel, a P2Y12 receptor antagonist; however, the prevalence of clopidogrel resistance (CR) percutaneous coronary interventions may exceed 60%. Few studies have investigated impact CR extracranial stenting, particularly transcarotid revascularization (TCAR). Methods Consecutive high-risk ≥ 18 years who underwent TCAR for high...

10.1177/17085381221142219 article EN Vascular 2022-11-25

Clopidogrel is effective at decreasing cardiovascular events in patients with peripheral artery disease (PAD); however, its effect on limb outcomes are less known. This study investigated the variability response to clopidogrel and relationship clinical outcomes.Three hundred subjects were enrolled Platelet Activity Cardiovascular Events (PACE) prior lower extremity revascularization, of whom 104 clopidogrel. Light transmission platelet aggregation was measured ADP 2 μm immediately...

10.1177/17085381221103417 article EN Vascular 2022-05-19
Coming Soon ...